A Clinical Evaluation of the Intersect ENT Sinus Device (ASCEND)

CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

June 12, 2018

Primary Completion Date

December 15, 2019

Study Completion Date

December 9, 2020

Conditions
Chronic Rhinosinusitis (Diagnosis)
Interventions
DEVICE

Drug-Coated Device

3000 mcg mometasone furoate-coated sinus dilation device

DEVICE

Control Device

Sinus dilation device without drug

Trial Locations (1)

21204

Centers for Advanced ENT Care, Baltimore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Intersect ENT

INDUSTRY

NCT03599271 - A Clinical Evaluation of the Intersect ENT Sinus Device (ASCEND) | Biotech Hunter | Biotech Hunter